StockData

Cannabis Bioscience International Holdings, Inc. (CBIH) stock

CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026Score 0/30
$0.00+0.00 (+33.33%)

Close on Oct 19, 2026Market cap $2.33MP/E –Yield –

Cannabis Bioscience International gross margin

Gross margin is gross profit as a percentage of revenue.

Cannabis Bioscience International's gross margin for the twelve months ending Feb 28, 2026 was 78.8%. For fiscal 2025 it was 86.8%, against 81.7% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025May 31, 202586.8%+5.1
FY2024May 31, 202481.7%+11.2
FY2023May 31, 202370.5%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q3 FY2026CQ1 2026Feb 28, 202672.8%+102.7
Q2 FY2026CQ4 2025Nov 30, 202580.3%−9.2
Q1 FY2026CQ3 2025Aug 31, 202566.4%−29.0
Q4 FY2025CQ2 2025May 31, 202587.0%+0.0
Q3 FY2025CQ1 2025Feb 28, 2025-29.9%−97.5
Q2 FY2025CQ4 2024Nov 30, 202489.5%+13.2
Q1 FY2025CQ3 2024Aug 31, 202495.3%+7.4
Q4 FY2024CQ2 2024May 31, 202487.0%+21.5
Q3 FY2024CQ1 2024Feb 29, 202467.6%+14.6
Q2 FY2024CQ4 2023Nov 30, 202376.3%−15.1
Q1 FY2024CQ3 2023Aug 31, 202387.9%–
Q4 FY2023CQ2 2023May 31, 202365.5%–
Q3 FY2023CQ1 2023Feb 28, 202352.9%–
Q2 FY2023CQ4 2022Nov 30, 202291.4%–

More Cannabis Bioscience International figures

See a number that looks wrong?